Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (10): 1320-1329.doi: 10.12092/j.issn.1009-2501.2026.10.003
Qi LOU1(
), Anran GUO1, Shuting YUAN1, Ting WANG1, Huiyu JIA2, Xiaoyu ZHU2, Dongmei YANG2, Manqin YANG3, Shengyong LUO1,2,*(
)
Received:2025-10-14
Revised:2025-12-28
Online:2026-10-26
Published:2026-11-11
Contact:
Shengyong LUO
E-mail:2446063266@qq.com;lsy770728@126.com
CLC Number:
Qi LOU, Anran GUO, Shuting YUAN, Ting WANG, Huiyu JIA, Xiaoyu ZHU, Dongmei YANG, Manqin YANG, Shengyong LUO. The mechanism of Qihong Tongluo Granule in regulating mitochondrial dynamics disorder and improving cerebral ischemia-reperfusion injury[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(10): 1320-1329.
Fig.1 Effect of QHTLG on the neurological functional impairment in rats ($\bar x $±s, n=8) cP<0.01, compared with sham group; eP<0.05, fP<0.01, compared with model group.
Fig.2 Effect of QHTLG on the apoptosis rate in cortical tissue ($\bar x $±s, n=5) A: representative TUNEL immunofluorescence staining images (green); B: quantification of apoptotic neurons. cP<0.01, compared with sham group; eP<0.05, fP<0.01, compared with model group.
Fig.3 Effect of QHTLG on apoptosis-related proteins in the cortical tissue ($\bar x $±s, n=5) A: Western blotting bands of apoptosis-related proteins; a: Sham; b: Model; c: Ginadol; d: QHTLG 2.7 g/kg; e: QHTLG 5.4 g/kg; f: QHTLG 10.8 g/kg; B-D: densitometric analysis of Cl-caspase-3, Bax and Bcl-2 expression. cP<0.01, compared with sham group; eP<0.05, fP<0.01, compared with model group.
| Group | Dose (g/kg) | MMP (RFU) | ROS (RFU) | ATP (μmol/g prot) |
| Sham | - | 5.64±0.76 | 474.80±75.22 | 391.80±35.77 |
| Model | - | 2.06±0.62c | 755.20±87.11c | 228.20±25.07c |
| Ginadol | 0.022 | 4.16±0.87f | 552.60±78.41f | 331.20±39.78f |
| QHTLG | 2.7 | 3.18±0.81e | 613.20±100.51e | 283.40±42.07e |
| 5.4 | 4.08±0.85f | 561.40±79.53f | 324.40±40.53f | |
| 10.8 | 4.24±0.92f | 544.80±70.11f | 334.80±37.86f |
Table 1 Effects of QHTLGs on MMP, ATP and ROS in the cortical tissue ($\bar x $±s, n=5)
| Group | Dose (g/kg) | MMP (RFU) | ROS (RFU) | ATP (μmol/g prot) |
| Sham | - | 5.64±0.76 | 474.80±75.22 | 391.80±35.77 |
| Model | - | 2.06±0.62c | 755.20±87.11c | 228.20±25.07c |
| Ginadol | 0.022 | 4.16±0.87f | 552.60±78.41f | 331.20±39.78f |
| QHTLG | 2.7 | 3.18±0.81e | 613.20±100.51e | 283.40±42.07e |
| 5.4 | 4.08±0.85f | 561.40±79.53f | 324.40±40.53f | |
| 10.8 | 4.24±0.92f | 544.80±70.11f | 334.80±37.86f |
Fig.4 Effect of QHTLG on the activity of mitochondrial respiratory chain complexes in the cortical tissue ($\bar x $±s, n=5) cP<0.01, compared with sham group; eP<0.05, fP<0.01, compared with model group.
Fig.6 Effect of QHTLG on the expression of mitochondrial dynamics-related proteins in the cortical tissue ($\bar x $±s, n=5) A: Western blotting bands of mitochondrial dynamics-related proteins; a: Sham; b: Model; c: Ginadol; d: QHTLG 2.7 g/kg; e: QHTLG 5.4 g/kg; f: QHTLG 10.8 g/kg; B-F: densitometric analysis of the expression of mitochondrial dynamics-related proteins. cP<0.01, compared with sham group; eP<0.05, fP<0.01, compared with model group.
| 1 | 余孝海, 金宇, 孙敏琼, 等. 杜鹃花总黄酮对脑缺血再灌注大鼠脑氧化应激损伤的改善作用[J]. 中国临床药理学与治疗学, 2025, 30 (2): 216- 221. |
| 2 |
Emaus JK, Fogo MG, Wider MJ, et al. The role of cardiolipin in mitochondrial dynamics and quality control in neuronal ischemia/reperfusion injury[J]. Cell Death Dis, 2025, 16 (1): 494.
doi: 10.1038/s41419-025-07786-8 |
| 3 |
Liu M, Yin Z, Li B, et al. Targeting Drp1 in cerebral ischemia–reperfusion injury: mechanisms and therapeutic implications[J]. CNS Neurosci Ther, 2025, 31 (8): e70590.
doi: 10.1111/cns.70590 |
| 4 |
Fogo GM, Raghunayakula S, Emaus KJ, et al. Mitochondrial dynamics and quality control regulate proteostasis in neuronal ischemia-reperfusion[J]. Autophagy, 2025, 21 (7): 1492- 1506.
doi: 10.1080/15548627.2025.2472586 |
| 5 |
Ge S, Wang L, Jin C, et al. Unveiling the neuroprotection effects of Volvalerenic acid A: mitochondrial fusion induction via IDO1-mediated Stat3-Opa1 signaling pathway[J]. Phytomedicine, 2024, 129, 155555.
doi: 10.1016/j.phymed.2024.155555 |
| 6 |
Modi J, Menzie-Suderam J, Xu H, et al. Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model[J]. J Biomed Sci, 2020, 27 (1): 19.
doi: 10.1186/s12929-019-0597-7 |
| 7 |
高玉菊, 杨满琴, 王丽, 等. 芪红通络颗粒对大鼠脑缺血再灌注损伤保护作用及其机制研究[J]. 安徽中医药大学学报, 2021, 40 (3): 64- 69.
doi: 10.3969/j.issn.2095-7246.2021.03.017 |
| 8 |
Chen C, Li C, Lan X, et al. Huang-Lian-Jie-Du decoction inhibits CD4+ T cell infiltration into CNS in MCAO rats by regulating BBB[J]. Phytomedicine, 2025, 141, 156607.
doi: 10.1016/j.phymed.2025.156607 |
| 9 |
Qian Y, Yang L, Chen J, et al. SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury[J]. J Neuroinflammation, 2024, 21 (1): 35.
doi: 10.1186/s12974-024-03026-6 |
| 10 |
Liu R, Yu Y, Ge Q, et al. Genistein-3'-sodium sulfonate promotes brain functional rehabilitation in ischemic stroke rats by regulating astrocyte polarization through NF-κB signaling pathway[J]. Chem Biol Interact, 2024, 400, 111159.
doi: 10.1016/j.cbi.2024.111159 |
| 11 |
Shuai Y, Xu D, Yang J, et al. Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia/reperfusion injury[J]. Sci Rep, 2024, 14 (1): 15175.
doi: 10.1038/s41598-024-64981-x |
| 12 |
Yingmin Z, Xinhua Q, Lihui L, et al. Long noncoding RNA MAGI2-AS3 regulates the H2O2 level and cell senescence via HSPA8[J]. Redox Biol, 2022, 54, 102383.
doi: 10.1016/j.redox.2022.102383 |
| 13 |
Yang W, Lei X, Liu F, et al. Meldonium, as a potential neuroprotective agent, promotes neuronal survival by protecting mitochondria in cerebral ischemia-reperfusion injury[J]. J Transl Med, 2024, 22 (1): 771.
doi: 10.1186/s12967-024-05222-7 |
| 14 |
van der Munnik SHM, Franken MCJ, Braakman MHT, et al. The hibernation-derived compound SUL-138 shifts the mitochondrial proteome towards fatty acid metabolism and prevents cognitive decline and amyloid plaque formation in an Alzheimer's disease mouse model[J]. Alzheimers Res Ther, 2022, 14 (1): 183.
doi: 10.1186/s13195-022-01127-z |
| 15 |
Li X, Li H, Xu Z, et al. Author correction: ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons[J]. Cell Death Dis, 2024, 15 (9): 653.
doi: 10.1038/s41419-024-07032-7 |
| 16 |
Zeng X, Zhang Y, Ma R, et al. Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis[J]. Mil Med Res, 2022, 9 (1): 68.
doi: 10.1186/s40779-022-00383-2 |
| 17 |
Howard JD, Naomi SO, Charles KO, et al. Inflammatory responses after ischemic stroke[J]. Semin Immunopathol, 2022, 44 (5): 625- 648.
doi: 10.1007/s00281-022-00943-7 |
| 18 | 岑娟, 张峰, 姬汴生. 缺血性中风抗氧化治疗的临床问题及研究进展[J]. 中国临床药理学与治疗学, 2013, 18 (4): 448- 454. |
| 19 |
Jie H, Lei C, Yang ZM, et al. The role of mitochondrial dynamics in cerebral ischemia-reperfusion injury[J]. Biomed Pharmacother, 2023, 162, 114671.
doi: 10.1016/j.biopha.2023.114671 |
| 20 |
张传武, 朱芸燕, 陈靖, 等. 线粒体在脑缺血再灌注损伤中的作用研究进展[J]. 河北医药, 2025, 47 (7): 1197- 1201.
doi: 10.3870/j.issn.1672-0741.24.08.013 |
| 21 |
Yuanyuan S, Lijian H, Xianxian Z, et al. Selenium alleviates cerebral ischemia/reperfusion injury by regulating oxidative stress, mitochondrial fusion and ferroptosis[J]. Neurochem Res, 2022, 47 (10): 2992- 3002.
doi: 10.1007/s11064-022-03643-8 |
| 22 |
Qian W, Jiao L, Zhiguo M, et al. Ligustilide attenuates ischemic stroke injury by promoting Drp1-mediated mitochondrial fission via activation of AMPK[J]. Phytomedicine, 2022, 95, 153884.
doi: 10.1016/j.phymed.2021.153884 |
| 23 |
Yuan JY, Chen T, Yang LY, et al. E2F1/CDK5/DRP1 axis mediates microglial mitochondrial division and autophagy in the pathogenesis of cerebral ischemia-reperfusion injury[J]. Clin Transl Med, 2025, 15 (2): e70197.
doi: 10.1002/ctm2.70197 |
| 24 |
Liu X, Li T, Tu X, et al. Mitochondrial fission and fusion in neurodegenerative diseases: Ca2+ signalling[J]. Mol Cell Neurosci, 2025, 132, 103992.
doi: 10.1016/j.mcn.2025.103992 |
| 25 | 齐格格, 董新刚, 李伟峰, 等. 视神经萎缩蛋白1介导的线粒体动力学在中枢神经系统疾病发生发展中的作用[J]. 中国比较医学杂志, 2025, 35 (4): 104- 113,134. |
| 26 |
Liang GF, Zandkarimi F, Lee J, et al. OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response[J]. Mol Cell, 2024, 84 (16): 3098- 3114.
doi: 10.1016/j.molcel.2024.07.020 |
| [1] | Xinyu ZHANG, Shaowen WEN, Fei ZHAO, Lili WU, Jionglu ZHANG, Zehai FANG, Hongjie LIU. Gastrodin attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by modulating the PI3K signaling pathway and reducing reactive oxygen species levels [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(9): 1153-1161. |
| [2] | Rufeng ZHOU, Ying ZHANG, Ziyuan MENG, Jie LIU, Mengqiong SHI, Yong LIAO, Jie XU, Haoran LI, Yanqing TAN, Huilin QIN, Liangliang JIA, Yan YOU. Tormentic acid protects alcohol induced GES-1 cells via regulating Keap-1/Nrf2 and NLRP3 inflammasome signaling pathways [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(8): 1034-1052. |
| [3] | Guangwei QI, Wanyu TONG, Jilu WANG, Jingwen GUO, Ruiqiao LI, Qilong WANG. Protective effects of Xueshuantong on mitochondrial dynamic balance, endothelial dysfunction, and atherosclerosis in diabetes [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(6): 798-807. |
| [4] | Mina GAO, Liya YANG, Shangying DUAN, Xinlu CHEN, Xiaoya LI, Bo QIAO, Yueying WU. Research progress on the prevention and treatment of high-altitude diseases by traditional Chinese medicine based on the "lung-brain axis" [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 675-682. |
| [5] | Kang ZENG, Weixin XING, Qingchun MU. Research progress of patchouli alcohol in the treatment of ischemia-related diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 691-699. |
| [6] | Qiankun DING, Dejie ZENG, Xiaqing SUN, Jili ZHAO, Qi SUN, Hongwei ZHU. Research progress on natural products in the treatment of autism spectrum disorder [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 700-708. |
| [7] | Weichen WANG, Yaping MA, Meng WANG, Qinglin LI, Hui CHENG. Therapeutic effect of emodin on cholestatic liver injury in mice based on CYP7A1 / FXR / SHP pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(2): 204-212. |
| [8] | LI Yanfei1, HUANG Can2, LUO Ping3, HE Fang4, HU Changping2. LOX-1 promotes hypoxia-induced autophagy and apoptosis in endothelial cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1017-1025. |
| [9] | YANG Huanran, WU Shengnan, GAO Qin. Dexmedetomidine alleviates ferroptosis in rat cerebral ischemia/reperfusion injury by inhibiting the Nrf2 pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 921-928. |
| [10] | LIU Dewei, WU Dong, HUANG Dan, ZHAO Xuanna, WU Bin. Research progress on non-coding RNA mediated apoptosis in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 968-976. |
| [11] | ZHANG Yidan, SUN Xinghua, QU Yang, HU Xiaoyang, ZHANG Miao. Research progress on the regulation of PI3K/Akt signaling pathway by active ingredients of traditional Chinese medicine in the treatment of cerebral ischemia-reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 820-827. |
| [12] | YANG Dongli, LI Jing, DUAN Lifang, ZHANG Wenjiang, LI Na, ZHANG Hong. Advances in the anti-fibrosis effect of oxidative stress-related regulatory protein Cygb [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 683-689. |
| [13] | JIA Dongye, PAN Zhi. Role of mitochondrial homeostasis in the pathogenesis of rheumatoid arthritis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 541-547. |
| [14] | GAO Wanli, ZHOU Qichun, WANG Sumei. Fructus Akebiae induces apoptosis via regulating ROS-mediated PI3K-Akt signaling pathway in non-small cell lung cancer cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 339-346. |
| [15] | YU Xiaohai, JIN Yu, SUN Minqiong, CONG Hui, GUO Qianying. Ameliorating effect of total flavonoids of rhododendron on brain oxidative stress injury in cerebral ischemia-reperfusion rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 216-221. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||